For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240916:nRSP3471Ea&default-theme=true
RNS Number : 3471E Agronomics Limited 16 September 2024
RNS Reach
16th September 2024
Agronomics (https://agronomics.im/) Limited (https://agronomics.im/)
("Agronomics" or the "Company")
Portfolio Company Presentation Series - Formo Bio GmbH
Agronomics (LSE: ANIC), a leading listed company in the field of cellular
agriculture, is pleased to announce that it will be hosting the fourth
presentation in its Capital Markets portfolio series.
The Agronomics' Capital Markets Investor Presentation Series comprises
individual presentations from industry-leading companies in the cell culture
and precision fermentation sector within the Agronomics portfolio. For each
presentation, the portfolio company's management team will provide in-depth
insights into the purpose, market demand, technical milestones, and growth
strategy of the company, together with a Question & Answer session at the
end of the presentation. Agronomics expects to hold, on average, a
presentation every eight weeks.
The presentation will include the senior management team at Formo Bio GmbH
("Formo") on 26 September 2024 at 15:00 BST. Attendees are able to register
for the event using the following link:
https://us02web.zoom.us/webinar/register/WN_xiVZVFEnTnaQMeb6rIAjmg#/registration
(https://us02web.zoom.us/webinar/register/WN_xiVZVFEnTnaQMeb6rIAjmg#/registration)
.
After registering, attendees will receive a confirmation email containing
information about joining the webinar.
Formo is an innovative European fermentation startup that is redefining the
future of cheese. Founded in 2019, with locations in Berlin and Frankfurt,
Formo develops animal-free alternatives that combine taste and sustainability.
Using state-of-the-art fermentation technology, Formo creates cheese
alternatives that taste great and contribute positively to the environment.
Learn more at https://formo.bio/ (https://formo.bio/) .
Formo recently announced that it has successfully raised US$ 61 million in its
Series B funding round which will help the company achieve key milestones,
including international expansion, diversifying the product range, driving
revenue growth and achieving net profitability by 2027. Formo will also invest
in its technology platform to accelerate the commercialisation of animal-free
casein products, which will expand the portfolio to include hard cheeses,
opening further opportunities in the market.
In addition to the new financing, Formo announced that its first two cheese
products Frischhain and Camembritz, are now available at over 2,000 REWE,
BILLA and METRO stores across Germany and Austria.
About Agronomics
Agronomics is a leading London-listed company focussing on investment
opportunities within the field of cellular agriculture. The Company has
established a portfolio of over 20 companies in this rapidly advancing sector.
It seeks to invest in companies owning technologies with defensible
intellectual property that offer new ways of producing food and materials with
a focus on products historically derived from animals. These technologies are
driving a major disruption in agriculture, offering solutions to improve
sustainability, as well as addressing human health, animal welfare and
environmental damage. This disruption will decouple supply chains from the
environment and animals and improve food security for the world's expanding
population. A full list of Agronomics' portfolio companies is available at
https://agronomics.im/ (https://agronomics.im/) .
For further information please contact:
Agronomics Limited Beaumont Cornish Limited Canaccord Genuity Limited Cavendish Capital Markets Limited Peterhouse Capital Limited SEC Newgate
The Company Nomad Joint Broker Joint Broker Joint Broker Public Relations
Jim Mellon Roland Cornish Andrew Potts Giles Balleny Lucy Williams Bob Huxford
Denham Eke James Biddle Harry Pardoe Michael Johnson Charles Goodfellow Anthony Hughes
Alex Aylen (Head of Equities) Charlie Combe
+44 (0) 1624 639396 +44 (0) 207 628 3396 +44 (0) 207 523 8000 +44 (0) 207 397 8900 +44 (0) 207 469 0936 agronomics@secnewgate.co.uk
info@agronomics.im
Nominated Adviser
Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated
Adviser and is authorised and regulated by the FCA. Beaumont Cornish's
responsibilities as the Company's Nominated Adviser, including a
responsibility to advise and guide the Company on its responsibilities under
the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed
solely to the London Stock Exchange. Beaumont Cornish is not acting for and
will not be responsible to any other persons for providing protections
afforded to customers of Beaumont Cornish nor for advising them in relation to
the proposed arrangements described in this announcement or any matter
referred to in it.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRAGPUWGBUPCGUQ